Contravir Pharmaceuticals (NASDAQ: CTRV) CEO: James Sapirstein INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today is James Sapirstein CEO for […]
Generation Next Franchise Brands (OTC: VEND) Chairman: Nick Yates CEO: Arthur Budman About: Generation NEXT Franchise Brands, Inc., based in San Diego, California, is a publicly traded company on the OTC Markets trading under the symbol […]
Founded in 2008, Acerus has quickly grown into a fully integrated company with expertise in all stages of the pharmaceutical product lifecycle, and focus in the therapeutic areas of Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction). […]
Interview with CEO Matt Simpson […]
US Cobalt is focused on the acquisition and development of high grade battery metal deposits in North America. The Iron Creek Cobalt Project, located in the prolific Idaho Cobalt Belt, is the focus of a 40-hole, 35,000 foot (10,700 metre) drill campaign to confirm a 1.3M ton grading 0.59% cobalt historical estimate (non-compliant with NI 43-101) and a Resource Estimate prepared in accordance with NI 43-101 is expected on the project in 2018.
[…]
Interview with William Waldrop, CEO […]
Interview with Sanjay Kalra, CFO […]
Management Interview […]
Interview with Scot Shaw, CEO and President […]
Interview with Dr. Pam Marrone, CEO and FOunder […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com